Josh Arnold Investment Consultant’s Starling Oncology STLN Stock Holding History

Josh Arnold Investment Consultant’s Portfolio STLN Stock Details STLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13.4M	Hold	2,464,359	–	–	8.42%	3
2026 Q1	$7.57M	Buy	2,464,359 +4,550	+0.2%	+$14K	6.47%	3
2025 Q4	$8.76M	Buy	2,459,809 +2,255,559	+1,104%	+$8.37M	6.53%	3
2025 Q3	$713K	Sell	204,250 -2,242,300	-92%	-$7.68M	0.57%	6
2025 Q2	$5.02M	Buy	2,446,550 +457,650	+23%	+$1.14M	4.35%	3
2025 Q1	$2.27M	Buy	+1,988,900	New	+$1.54M	1.89%	7
2024 Q1	–	Sell	-1,856,329	Closed	-$3.79M	–	24
2023 Q4	$3.79M	Sell	1,856,329 -21,143	-1%	-$36.7K	3.62%	3
2023 Q3	$2.65M	Buy	1,877,472 +819,321	+77%	+$848K	1.55%	4
2023 Q2	$582K	Buy	1,058,151 +941,308	+806%	+$498K	0.57%	11
2023 Q1	$79K	Buy	116,843 +12,443	+12%	+$15.9K	0.09%	15
2022 Q4	$172K	Buy	+104,400	New	+$293K	0.25%	14

Other funds holding STLN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

CenterBook Partners Greenwich, Connecticut $2.04B AUM 35.27% 1-Year Est. Return

Josh Arnold Investment Consultant's STLN Position: Q2 2026 in Review

Josh Arnold Investment Consultant held its Starling Oncology (STLN) position steady in Q2 2026 at 2,464,359 shares worth $13.4M. The position accounts for 8.42% of the portfolio, ranked #3.

Josh Arnold Investment Consultant first reported a position in STLN in Q4 2022 and has held it in 11 quarters since. 119 funds tracked by Wall St. Rank hold STLN as of Q2 2026.

Josh Arnold Investment Consultant held 2,464,359 shares of Starling Oncology worth $13.4M as of Q2 2026.
Josh Arnold Investment Consultant left its Starling Oncology share count unchanged in Q2 2026.
Starling Oncology made up 8.42% of Josh Arnold Investment Consultant's portfolio in Q2 2026, its #3 holding.
Josh Arnold Investment Consultant first reported a position in Starling Oncology in Q4 2022 and has held it in 11 quarters since.
119 funds tracked by Wall St. Rank held Starling Oncology as of Q2 2026.

Based on Josh Arnold Investment Consultant's 13F filing for Q2 2026, filed 14 Aug 2026.